ResMed Past Earnings Performance
Past criteria checks 5/6
ResMed has been growing earnings at an average annual rate of 16.7%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 11.7% per year. ResMed's return on equity is 21%, and it has net margins of 21.8%.
Key information
16.7%
Earnings growth rate
16.2%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 11.7% |
Return on equity | 21.0% |
Net Margin | 21.8% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26ResMed (NYSE:RMD) Could Be Struggling To Allocate Capital
Apr 24Here's Why ResMed (NYSE:RMD) Has Caught The Eye Of Investors
Apr 09A Look At The Intrinsic Value Of ResMed Inc. (NYSE:RMD)
Mar 26ResMed goes ex dividend tomorrow
Feb 07ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Feb 06Revenue & Expenses Breakdown
How ResMed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 4,685 | 1,021 | 917 | 308 |
31 Mar 24 | 4,584 | 958 | 916 | 305 |
31 Dec 23 | 4,504 | 890 | 914 | 304 |
30 Sep 23 | 4,375 | 907 | 903 | 300 |
30 Jun 23 | 4,223 | 898 | 874 | 288 |
31 Mar 23 | 4,016 | 863 | 826 | 274 |
31 Dec 22 | 3,763 | 809 | 780 | 264 |
30 Sep 22 | 3,624 | 786 | 755 | 257 |
30 Jun 22 | 3,578 | 779 | 738 | 254 |
31 Mar 22 | 3,539 | 779 | 726 | 249 |
31 Dec 21 | 3,444 | 522 | 704 | 238 |
30 Sep 21 | 3,349 | 500 | 688 | 231 |
30 Jun 21 | 3,197 | 475 | 670 | 225 |
31 Mar 21 | 3,091 | 457 | 654 | 218 |
31 Dec 20 | 3,092 | 699 | 666 | 213 |
30 Sep 20 | 3,028 | 680 | 668 | 208 |
30 Jun 20 | 2,957 | 622 | 677 | 202 |
31 Mar 20 | 2,892 | 513 | 683 | 201 |
31 Dec 19 | 2,784 | 455 | 675 | 197 |
30 Sep 19 | 2,699 | 419 | 665 | 190 |
30 Jun 19 | 2,607 | 405 | 645 | 181 |
31 Mar 19 | 2,525 | 446 | 630 | 169 |
31 Dec 18 | 2,455 | 450 | 614 | 159 |
30 Sep 18 | 2,405 | 335 | 604 | 157 |
30 Jun 18 | 2,340 | 316 | 600 | 155 |
31 Mar 18 | 2,273 | 307 | 591 | 152 |
31 Dec 17 | 2,196 | 285 | 581 | 150 |
30 Sep 17 | 2,125 | 352 | 569 | 147 |
30 Jun 17 | 2,067 | 342 | 554 | 144 |
31 Mar 17 | 2,029 | 324 | 532 | 142 |
31 Dec 16 | 1,968 | 327 | 518 | 135 |
30 Sep 16 | 1,893 | 346 | 496 | 126 |
30 Jun 16 | 1,839 | 352 | 488 | 119 |
31 Mar 16 | 1,773 | 357 | 481 | 113 |
31 Dec 15 | 1,742 | 357 | 475 | 112 |
30 Sep 15 | 1,710 | 353 | 479 | 112 |
30 Jun 15 | 1,679 | 353 | 479 | 115 |
31 Mar 15 | 1,641 | 353 | 478 | 118 |
31 Dec 14 | 1,616 | 352 | 473 | 121 |
30 Sep 14 | 1,578 | 348 | 466 | 121 |
30 Jun 14 | 1,555 | 345 | 450 | 118 |
31 Mar 14 | 1,554 | 331 | 443 | 118 |
31 Dec 13 | 1,540 | 325 | 441 | 119 |
30 Sep 13 | 1,532 | 317 | 434 | 120 |
Quality Earnings: RMD has high quality earnings.
Growing Profit Margin: RMD's current net profit margins (21.8%) are higher than last year (21.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: RMD's earnings have grown by 16.7% per year over the past 5 years.
Accelerating Growth: RMD's earnings growth over the past year (13.7%) is below its 5-year average (16.7% per year).
Earnings vs Industry: RMD earnings growth over the past year (13.7%) exceeded the Medical Equipment industry 5.5%.
Return on Equity
High ROE: RMD's Return on Equity (21%) is considered high.